People with diets rich in ultra-processed foods, those typically loaded with harmful additives and preservatives, have a 26% higher risk…
Articles by Margarida Maia, PhD
The first patient has been dosed in a Phase 2a clinical trial testing ReAlta Life Sciences’ RLS-0071 in adults…
A Phase 2a clinical trial of AstraZeneca’s experimental therapy mitiperstat is now recruiting adults with moderate to severe…
Pulmonary (lung) rehabilitation nearly halves the odds of people with chronic obstructive pulmonary disease (COPD) experiencing an exacerbation, and…
The number of people worldwide with chronic obstructive pulmonary disease (COPD) is predicted to increase by 23% in three…
The U.S. Food and Drug Administration (FDA) has agreed to review Verona Pharma’s application seeking approval of inhaled ensifentrine…
Lupin Pharmaceuticals has penned a deal with low-cost pharmacy Mark Cuban Cost Plus Drugs and the COPD Foundation…
People who take inhaled corticosteroids for their chronic obstructive pulmonary disease (COPD) may be at lower risk for developing…
Many African Americans with clear symptoms of chronic obstructive pulmonary disease (COPD) don’t get a formal diagnosis because current…
A first person with chronic obstructive pulmonary disease (COPD) has been dosed with ensifentrine, an inhaled medication in the…